BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23539730)

  • 1. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.
    Fischer E; Adolf C; Pallauf A; Then C; Bidlingmaier M; Beuschlein F; Seissler J; Reincke M
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2513-20. PubMed ID: 23539730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
    Tsurutani Y; Sugisawa C; Ishida A; Inoue K; Saito J; Omura M; Nagasaka S; Nishikawa T
    Endocr J; 2017 Mar; 64(3):339-346. PubMed ID: 28111382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity in patients with primary aldosteronism: a follow-up study.
    Catena C; Lapenna R; Baroselli S; Nadalini E; Colussi G; Novello M; Favret G; Melis A; Cavarape A; Sechi LA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3457-63. PubMed ID: 16822818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible association between primary aldosteronism and a lower beta-cell function.
    Mosso LM; Carvajal CA; Maiz A; Ortiz EH; Castillo CR; Artigas RA; Fardella CE
    J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism.
    Okazaki-Hada M; Moriya A; Nagao M; Oikawa S; Fukuda I; Sugihara H
    J Diabetes Investig; 2020 Nov; 11(6):1511-1519. PubMed ID: 32470155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans.
    Adler GK; Murray GR; Turcu AF; Nian H; Yu C; Solorzano CC; Manning R; Peng D; Luther JM
    Hypertension; 2020 May; 75(5):1251-1259. PubMed ID: 32172621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
    Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased insulin sensitivity in patients with aldosterone producing adenoma.
    Ishimori M; Takeda N; Okumura S; Murai T; Inouye H; Yasuda K
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):433-8. PubMed ID: 7955454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
    Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
    Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
    Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
    Lenzini L; Prisco S; Vanderriele PE; Lerco S; Torresan F; Maiolino G; Seccia TM; Iacobone M; Rossi GP
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3726-3734. PubMed ID: 30865228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy.
    Volpe C; Hamberger B; Höög A; Mukai K; Calissendorff J; Wahrenberg H; Zedenius J; Thorén M
    Clin Endocrinol (Oxf); 2015 May; 82(5):639-47. PubMed ID: 25347939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma.
    Komada H; Hirota Y; So A; Nakamura T; Okuno Y; Fukuoka H; Iguchi G; Takahashi Y; Sakaguchi K; Ogawa W
    Diabetes Metab; 2020 Jun; 46(3):236-242. PubMed ID: 31676325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism.
    Grewal S; Fosam A; Chalk L; Deven A; Suzuki M; Correa RR; Blau JE; Demidowich AP; Stratakis CA; Muniyappa R
    Endocrine; 2021 Apr; 72(1):96-103. PubMed ID: 33462741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.
    Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.
    Weigel M; Riester A; Hanslik G; Lang K; Willenberg HS; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M
    Eur J Endocrinol; 2015 Apr; 172(4):443-50. PubMed ID: 25630564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.